psalexa
logo

Aneurysm Therapeutics Pipeline Analysis

Aneurysm Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11216
Available Format:

Aneurysm is a type of disorder that causes bulge formation in arteries. The disease generally occurs due to damaging of arteries. The bulge formation leads an increased force against an injured wall inside the artery. This further leads to rupturing of the artery and severe bleeding. Aneurysm mostly occurs in aorta that supply oxygen-rich blood from the heart to other parts of the body. There are certain risk factors associated with aneurysm such as high blood pressure, smoking, atherosclerosis, and aging. Bacterial infection and syphilis are also known to cause aortic aneurysm. The University of California, San Francisco is in the process of developing infliximab as an anti-human tumor necrosis factor monoclonal antibody for the treatment of aneurysm. The Rush University is in the process of developing estradiol for the treatment of aneurysm. Some of the universities having the pipeline of aneurysm include Rush University, University of California, San Francisco, and others.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry